Effect of angiotensin II receptor blockade on bronchial responsiveness in asthmatic subjects

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 3, 1998, Pages 521-522

  Dicpinigaitis, Peter V ^a,b   Dobkin, Jay B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Albert Einstein Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN; LOSARTAN POTASSIUM; METHACHOLINE CHLORIDE; SALBUTAMOL;

ADULT; ANGIOTENSIN BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; ASTHMA; DIABETIC NEPHROPATHY; DOSIMETRY; FEMALE; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; VASCULAR DISEASE;

EID: 0031691172     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70143-5     Document Type: Article

References (6)

1. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-54.
2. Millar EA, Angus RM, Hulks G, Morton JJ, Connell JMC, Thomson NC. Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax 1994;49:492-5.
3. Millar EA, Nally JE, Thomson NC. Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. Eur Respir J 1995;8:1838-41.
4. Csajka C, Buclin T, Brunner HR, Biollaz J. Pharmacokinetic-pharmaco-dynamic profile of angiotensin II receptor antagonists. Clin Pharmacokinet 1997;32:1-29.
5. Dicpinigaitis PV, Thomas SA, Sherman MB, Gayle YE, Rosenstreich DL. Losartan-induced bronchospasm. J Allergy Clin Immunol 1996;98:1128-30.
6. Sasaki M, Fujimura A, Harada K, Sunaga K, Ebihara A. Clinical pharmacology of multiple-dose losartan, an angiotensin II receptor antagonist, in patients with essential hypertension. J Clin Pharmacol 1996;36:403-8.